Ovid Therapeutics SEC Filing: Effectiveness Notice
Ticker: OVID · Form: EFFECT · Filed: Apr 27, 2026 · CIK: 0001636651
| Field | Detail |
|---|---|
| Company | Ovid Therapeutics Inc. (OVID) |
| Form Type | EFFECT |
| Filed Date | Apr 27, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing-notice, effectiveness, registration-statement
TL;DR
Ovid Therapeutics SEC filing EFFECT accepted 4/27/26, effectiveness date 4/24/26.
AI Summary
Ovid Therapeutics Inc. filed an EFFECT form, indicating the effectiveness of a registration statement. The filing was accepted on April 27, 2026, with an effectiveness date of April 24, 2026. The company's mailing and business address is 441 Ninth Avenue, 14th Floor, New York, NY 10001.
Why It Matters
This filing signifies that a registration statement for Ovid Therapeutics Inc. has become effective, which is a crucial step for certain securities offerings or corporate actions.
Risk Assessment
Risk Level: low — This filing is a procedural notice of effectiveness and does not inherently introduce new financial or operational risks.
Key Numbers
- 2026-04-27 — Acceptance Date (Date the filing was accepted by the SEC.)
- 2026-04-24 — Effectiveness Date (Date the registration statement became effective.)
Key Players & Entities
- Ovid Therapeutics Inc. (company) — Filer
- 441 NINTH AVENUE, 14TH FLOOR NEW YORK NY 10001 (address) — Mailing and Business Address
- 212-776-4381 (phone_number) — Business Phone Number
FAQ
What type of filing is this?
This is an EFFECT filing, which is a Notice of Effectiveness.
When was this filing accepted by the SEC?
The filing was accepted on April 27, 2026.
What is the effectiveness date mentioned in the filing?
The effectiveness date is April 24, 2026.
What is Ovid Therapeutics Inc.'s business address?
Ovid Therapeutics Inc.'s business address is 441 Ninth Avenue, 14th Floor, New York, NY 10001.
What is the CIK number for Ovid Therapeutics Inc.?
The CIK number for Ovid Therapeutics Inc. is 0001636651.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 27, 2026 regarding Ovid Therapeutics Inc. (OVID).